Professor Stuart Elborn
Centre for Experimental Medicine, Institute for Health Sciences, School of Medicine, Dentistry and Biomedical Sciences (MDBS)
Professor Elborn is a well-established international leader in healthcare having driven major changes in healthcare delivery in the field of cystic fibrosis and bronchiectasis.
Prior to taking up his current post at Queen’s University Belfast, Professor Elborn was Clinical Professor of Respiratory Medicine/Consultant Physician and Director of Adult Cystic Fibrosis and Chronic Lung Infection at the National Heart and Lung Institute, Imperial College and Royal Brompton Hospital London.
He has spent decades researching Cystic Fibrosis (CF) and his work has led to major breakthroughs in treating the condition. In all his research, Professor Elborn endeavours to bring scientists and clinicians together to promote inter-disciplinary research. He has been successful in developing programmes of research across disciplines, hospitals and universities in Northern Ireland as well as across the UK and Europe.
In 2013 he received a CBE for services to healthcare in Northern Ireland.
FieldsBronchiectasis Cystic Fibrosis Health Medicine Respiratory
Areas of Expertise
Medicine, health, Cystic Fibrosis, bronchiectasis, Respiratory
Professor Elborn has extensive media experience.
New treatment brings hope on cystic fibrosis: Thousands of patients could have lives transformed by new drug for most common form of the condition, Daily Mail 18/05/2015
Queen’s scientist makes major cystic fibrosis breakthrough, GM Journal 27/06/2014
Cystic fibrosis patients to be treated at home using new smartphone scheme; Evening Standard 29/01/2018
For more information or to book an interview, email email@example.comAcademic Profile